Bob, you are right of course, but it is hard to really see SOL as a diversified investment house with a history of 'steady as she goes', suddenly take on the qualities that drove CSL as a highly focused leading niche operator in the market of plasma and blood products.
How much higher can we go?, page-91
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SOL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$32.97 |
Change
0.320(0.98%) |
Mkt cap ! $12.41B | |||
| Open | High | Low | Value | Volume |
| $32.80 | $33.10 | $32.65 | $7.381M | 224.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 737 | $32.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $33.06 | 1016 | 2 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| SOL (ASX) Chart |
